VNN1 and metabolic dysfunction-associated steatohepatitis: Nevertheless, Hep-EVs as noted earlier were also enriched in the enzyme VNN-1, which promoted angiogenesis and induced liver damage in NASH, hence representing another potential biomarker (55).